EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model
The purpose of this paper is to investigate the possible mechanisms of resistance to chemotherapy in melanoma from the perspective of molecular biology and to discuss the strategies to overcome them. Cisplatin, a DNA-damaging compound that triggers apoptotic cell death, is commonly used in the treat...
Main Authors: | Xiaokun Yang, Yadong Yang, Shuqian Tang, Hui Tang, Guihong Yang, Qiaoyu Xu, Jinjin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-09-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861315001929 |
Similar Items
-
Biochemical and biophysical characterization of four EphB kinase domains reveals contrasting thermodynamic, kinetic and inhibition profiles
by: Ross C. Overman, et al.
Published: (2013-06-01) -
A Chemical-Genetic Study of EphB Receptor Tyrosine Kinase Signaling in the Developing Nervous System
by: Soskis, Michael
Published: (2012) -
Optogenetic activation of EphB2 receptor in dendrites induced actin polymerization by activating Arg kinase
by: Clifford Locke, et al.
Published: (2017-12-01) -
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma
by: Shilpa Bhatia, et al.
Published: (2017-03-01) -
Ligand-induced downregulation of the kinase-dead EphB6 receptor
Published: (2015)